Echinocandins, specifically Micafungin and Anidulafungin are critical lifesaving drugs, however the manufacturing processes is lengthy, difficult and inefficient. As a result, production costs are very high (up to INR 1 Crore/kg).
Iosynth is developing a biocatalytic process that will reduce manufacturing time by half, double yields, and thereby reducing manufacturing costs substantially. This novel and improved biocatalytic process will be sustainable and have superior economics compared to today’s process.
Iosynth has been awarded with a development grant from BIRAC to fund this R&D project.
For more details on this project, please contact us: contact [at] iosynth.com or via the contact form on this website.